PanGenex expects release of television program on Calci-CLEAR dietary supplement

PanGenex Corporation announced today that it anticipates the release of its long form television program, demonstrating the benefits of Calci-CLEAR™, its patent pending dietary supplement that addresses soft tissue calcification, pursuant to its partnership with Incredible Discoveries® in early 2010.

Report on the US intranasal drug delivery market

Research and Markets (http://www.researchandmarkets.com/research/1b2b29/intranasal_drug_de) has announced the addition of the “Intranasal Drug Delivery - US Market Trends & Analysis” report to their offering.

Latin American pharmaceutical market to grow up to $51.3bn in 2014

Research and Markets (http://www.researchandmarkets.com/research/b82621/latin_american_pha) has announced the addition of the “Latin American Pharmaceutical Market Outlook To 2014: Policy Environment, Market Analysis, Forecasts and Growth Opportunities” report to their offering.

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

ChemGenex Pharmaceuticals Limited announced today that the European Medicines Agency (”EMEA”) has determined that the Marketing Authorization Application (”MAA”) for omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia (CML) patients who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation is valid.

Cromoz’s new drug delivery system to reduce amount of drugs used in cancer treatment

Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a [...]

Detailed report on anxiety drug pipeline from Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/3365ab/anxiety_therapy_ar) has announced the addition of the “Anxiety Therapy Area Pipeline Report” report to their offering.

Agriflu approved to prevent diseases caused by influenza virus subtypes A and B

The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B.

New Disease Among HIV-infected Gay Men

A rare parasitic disease, which normally only is transmitted by contaminated water, has been shown to be transmitted by gay sex between hiv-positive men. In the industrial world the disease is virtually absent, but from now on that could change. For this observation, Taiwanese researcher Chieng-Ching Hung received a doctorate from the University of Antwerp [...]

Tripep completes clinical trial of ChronVac-C for Hepatitis C virus treatment

All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep’s therapeutic vaccine ChronVac-C have now been collected. The treatment was found to be safe, immunogenic and had transient effects on the serum levels of hepatitis C virus.

Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep

The Board of Directors of Tripep AB (publhas on the 27th of November 2009, based on the authorization by the Annual General Meeting resolved to carry out a rights issue.